Who May Apply
Organizations that are exempt from federal income taxes under Section 501(c)(3) of the Internal Revenue Code, contributions to which are deductible under Section170 of the Internal Revenue Code. The organization should qualify as a public charity under Section 509(a)(1) or (a)(2) of the Internal Revenue Code.
Organizations are permitted to submit multiple grant requests for different research projects.
Funding Areas of Interest
The Foundation is interested in supporting research that is aimed at discovering the causes of and finding a cure for ALS.
What We Fund
The Foundation funds research that is innovative and aggressive. We encourage partnerships and collaborative efforts in proposing initiatives to fill gaps not currently being investigated and that involve novel approaches. The research must be of high scientific merit. The Foundation will fund up to 10% in indirect costs.
The Foundation does not provide funds for support groups, education initiatives, medical equipment, or capital projects. Further, the Foundation will not fund multi-year grants, although an organization is permitted to submit an application for continued funding of a research project in the subsequent grant cycle.
The next proposal deadline is August 12, 2016. Applications are available through our online grant software (online link will be available on ALS “Grant Application” page in Spring 2016). Proposals will be reviewed in November 2016 and distribution of awards will be made prior to the end of December 2016.
Applications are reviewed by an Advisory Committee comprised of scientific researchers, neurologists, and others who have had close relationships with friends and family members afflicted with ALS. The Advisory Committee makes funding recommendations to the Foundation’s Trustees who make the final funding decisions. Advisory Committee Members include:
Barbara A. Fries, M.D (Chair)
John F. Coyle, M.D.
Francis Daniel Duffy, M.D., M.A.C.P.
David R. Gooden, Ph.D, J.D.
Joseph C. Masdeu, M.D., Ph.D
William Q. Sargent, Ph.D